Cardiovascular risk factors in a mexican middle-class urban population. The lindavista study. baseline data;Factores de riesgo cardiovascular en mexicanos de clase media: El estudio lindavista. Datos basales

Archivos de Cardiologia de Mexico

Volumn 83, Issue 4, 2013, Pages 249-256

  Meaney, Alejandra ^a   Ceballos Reyes, Guillermo ^b   Gutierrez Salmean, Gabriela ^b   Samaniego Méndez, Virginia ^a   Vela Huerta, Agustín ^a   Alcocer, Luis ^c   Zárate Chavarría, Elisa ^a   Mendoza Castelán, Emma ^a   Olivares Corichi, Ivonne ^b   García Sánchez, Rubén ^b   Martínez Marroquín, Yolanda ^b   Ramírez Sánchez, Israel ^b   Meaney, Eduardo ^a  

^a HOSPITAL REGIONAL 1 DE OCTUBRE   (Mexico)

^b INSTITUTO POLITÉCNICO NACIONAL   (Mexico)

^c HOSPITAL GENERAL DE MÉXICO   (Mexico)

Author keywords

Hypertension; Lipids; Mexico; Obesity; Risk factors; Smoking

Indexed keywords

CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ABDOMINAL OBESITY; ADULT; AGED; ARTICLE; BLOOD PRESSURE; BODY MASS; BODY WEIGHT; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CLINICAL PRACTICE; DYSLIPIDEMIA; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MERCURY SPHYGMOMANOMETER; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; PROGNOSIS; PROSPECTIVE STUDY; QUESTIONNAIRE; SMOKING; URBAN POPULATION; WAIST CIRCUMFERENCE; CARDIOVASCULAR DISEASES; HEALTH; MEXICO; MIDDLE AGED; RISK FACTOR; SOCIAL CLASS;

ADULT; AGED; CARDIOVASCULAR DISEASES; FEMALE; HUMANS; MALE; MEXICO; MIDDLE AGED; PROSPECTIVE STUDIES; RISK FACTORS; SOCIAL CLASS; URBAN HEALTH; URBAN POPULATION;

EID: 84890047605     PISSN: 14059940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.acmx.2013.05.002     Document Type: Article

References (48)

1. Huang PL. A comprehensive definition for metabolic syndrome. Dis Model Mech. 2009;2:231-7
2. Castelli WP, Anderson K. A population at risk: prevalence of high cholesterol levels in hypertensive patients in the Framingham Study. Am J Med. 1986;80:23-32
3. Castelli WP, Garrison RJ, Wilson PW, et al. Incidence of coronary heart disease and lipoprotein cholesterol levels: the Framingham Study. J Am Med Assoc. 1986;256:2835-8
4. Stamler J, Wentworth D, Neaton JD. Is relationship between serum cholesterol and risk of premature death from coronary heart disease continuous and graded? Findings in 356,222 primary screenees of the Multiple Risk Factor Intervention Trial (MRFIT). J Am Med Assoc. 1986;256:2823-8
5. Keys A. Coronary heart disease in seven countries. Nutrition. 1997;13:250-2
6. Assmann G, Schulte H. The importance of triglycerides: results from the Prospective Cardiovascular Munster (PROCAM) Study. Eur J Epidemiol. 1992;8:99-103
7. Assmann G, Schulte H. The Prospective Cardiovascular Munster Study: prevalence and prognostic significance of hyperlipidemia in men with systemic hypertension. Am J Cardiol. 1987;59:9G-17G.
8. Assmann G, Schulte H, Seedorf U. Cardiovascular risk assessment in the metabolic syndrome: results from the Prospective Cardiovascular Munster (PROCAM) Study. Int J Obes. 2008;32:S11-6
9. Anand SS, Islam S, Rosengren A, et al. Risk factors for myocardial infarction in women and men: insights from the INTERHEART study. Eur Heart J. 2008;29:932-40
10. Wilding J, Finer N. Obesity and risk of myocardial infarction: the INTERHEART study. Lancet. 2006;367:1053
11. Yusuf S, Hawken S, Ounpuu S, et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet. 2004;364:937-52
12. Sanchez-Castillo CP, Velasquez-Monroy O, Lara-Esqueda A, et al. Diabetes and hypertension increases in a society with abdominal obesity: results of the Mexican National Health Survey 2000. Publ Health Nutr. 2005;8:53-60
13. Rivera JA, Barquera S, Campirano F, et al. Epidemiological and nutritional transition in Mexico: rapid increase of noncommunicable chronic diseases and obesity. Publ Health Nutr. 2002;5:113-22
14. Meaney E, Lara-Esqueda A, Ceballos-Reyes GM, et al. Cardiovascular risk factors in the urban Mexican population: the FRIMEX study. Publ Health. 2007;121:378-84
15. Rojas R, Aguilar-Salinas CA, Jimenez-Corona A, et al. Metabolic syndrome in Mexican adults: results from the National Health and Nutrition Survey 2006. Sal Pub Mex. 2010;52:S11-8
16. World Medical Association. Declaration of Helsinki: ethical principles for medical research involving human subjects. J Ind Med Assoc. 2009;107:403-5
17. Diario Oficial de la Federación. Ley General de Salud, Reglamento de Investigación Clínica. Mexico: Diario Oficial de la Federación; 1986
18. International Conference on Harmonisation. Guidelines on Good Clinical Practice. Int Digest Health Legis. 1997;48:231-4
19. Fagerstrom KO, Schneider NG. Measuring nicotine dependence: a review of the Fagerstrom Tolerance Questionnaire. J Behav Med. 1989;12:159-82
20. Lohman T, Roche A, Martorell R. Anthropometric standardization reference manual. EUA: Human Kinetics; 1988
21. Pickering TG, Hall JE, Appel LJ, et al. Recommendations for blood pressure measurement in humans and experimental animals: Part 1: Blood pressure measurement in humans: a statement for professionals from the Subcommittee of Professional and Public Education of the American Heart Association Council on High Blood Pressure Research. Circulation. 2005;111:697-716
22. Ahumada-Ayala M, Calzada-León R, Canale-Huerta JM, et al. Recomendaciones de la Segunda Reunión de Expertos en Dislipidemias Organizada por la Asociación Mexicana para la Prevención de la Aterosclerosis y sus Complicaciones, A.C. Lineamientos sobre la detección el manejo diagnóstico y el tratamiento dietario y farmacológico de la hipercolesterolemia y la hipertrigliceridemia. Rev Mex Cardiol. 1996;7: 7-24
23. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972;18:499-502
24. Thomas GN, Ho SY, Janus ED, et al. The US National Cholesterol Education Programme Adult Treatment Panel III (NCEP ATP III) prevalence of the metabolic syndrome in a Chinese population. Diabetes Res Clin Pract. 2005;67:251-7
25. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2012;35:S64-71
26. Cuddy ML. Treatment of hypertension: guidelines from JNC 7 (the seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure 1). J Practical Nurs. 2005;55:17-21
27. Chobanian AV, Bakris GL, Black HR, et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. J Am Med Assoc. 2003;289:2560-72
28. Nucifora G, Schuijf JD, van Werkhoven JM, et al. Prevalence of coronary artery disease across the Framingham risk categories: coronary artery calcium scoring and MSCT coronary angiography. J Nucl Cardiol. 2009;16:368-75
29. Lemieux I, Lamarche B, Couillard C, et al. Total cholesterol/HDL cholesterol ratio vs LDL cholesterol/HDL cholesterol ratio as indices of ischemic heart disease risk in men: the Quebec Cardiovascular Study. Arch Intern Med. 2001;161:2685-92
30. Sanchez-Castillo CP, Velazquez-Monroy O, Berber A, et al. Anthropometric cutoff points for predicting chronic diseases in the Mexican National Health Survey 2000. Obes Res. 2003;11:442-51
31. Grundy SM, Pasternak R, Greenland P, et al. Assessment of cardiovascular risk by use of multiple-risk-factor assessment equations: a statement for healthcare professionals from the American Heart Association and the American College of Cardiology. Circulation. 1999;100:1481-92
32. Posadas-Romero C, Tapia-Conyer R, Lerman-Garber I, et al. Cholesterol levels and prevalence of hypercholesterolemia in a Mexican adult population. Atherosclerosis. 1995;118: 275-84
33. Cueto-Garcia L, Barrios R, Alva M, et al. Prevalence and severity of coronary atherosclerosis in males living in Mexico City: the Mexico City project. Cardiology. 1988;75:387-92
34. Secreatría de Salud. Encuesta Nacional de Enfermedades Crónicas. México: Secreatría de Salud; 1994
35. Instituto Nacional de Salud Pública. Encuesta Nacional de Salud 2000. México: Instituto Nacional de Salud Pública; 2000
36. Olaiz-Fernández G, Rivera-Dommarco J, Shamah-Levy T, et al. Encuesta Nacional de Salud y Nutrición 2006. Cuernavaca, México: Instituto Nacional de Salud Pública; 2006
37. Popkin BM. The nutrition transition in low-income countries: an emerging crisis. Nutr Rev. 1994;52:285-98
38. Popkin BM, Adair LS, Ng SW. Global nutrition transition and the pandemic of obesity in developing countries. Nutr Rev. 2012;70:3-21
39. Redinger RN. The pathophysiology of obesity and its clinical manifestations. Gastroenterol Hepatol. 2007;3:856-63
40. Ribeiro Filho FF, Mariosa LS, Ferreira SR, et al. Visceral fat and metabolic syndrome: more than a simple association. Arq Bras Endocrinol Metabol. 2006;50:230-8
41. Baños-González M, Cantú-Brito C, Chiquete E, et al. Presión arterial sistólica y pronóstico funcional en pacientes con enfermedad vascular cerebral aguda: Registro mexicano de enfermedad vascular cerebral. Arch Cardiol Mex. 2011;81:169-75
42. Cárdenas M, Vallejo M. Some socioeconomic characteristics of acute myocardial infarction patients in the Instituto Nacional de Cardiología Ignacio Chávez. Comparison of two decades: 1954-1964 and 1997-2007. Arch Cardiol Mex. 2011;81: 87-92
43. Aguilar-Salinas CA, Olaiz G, Valles V, et al. High prevalence of low HDL cholesterol concentrations and mixed hyperlipidemia in a Mexican nationwide survey. J Lipid Res. 2001;42:1298-307
44. Gutiérrez-Salmeán G, Ceballos G, Ramírez-Sánchez I. Obesity and the metabolic syndrome: future therapeutics based on novel molecular pathways. Clin Invest Arterio. 2012;24:204-11
45. Frey P, Waters DD. Tobacco smoke and cardiovascular risk: a call for continued efforts to reduce exposure. Curr Opin Cardiol. 2011;26:424-8
46. Secretaría de Salud Encuesta Nacional de Adicciones 2008. México: Instituto Nacional de Salud Pública; 2008
47. Schargrodsky H, Hernandez-Hernandez R, Champagne BM, et al. CARMELA: assessment of cardiovascular risk in seven Latin American cities. Am J Med. 2008;121:58-65
48. Sistema Nacional de Información en Salud. Mortalidad: principales causas de mortalidad general [online]; 2011. Available from http://sinais.salud.gob.mx/mortalidad/ [accessed 09.10.2011].